Articles

• FDA Approves First and Only Blood-Based Colorectal Cancer Screening Test
• Imbruvica Now FDA Approved for First-Line Treatment of Patients with CLL
• Gazyva Approved for the Treatment of Relapsed or Refractory Follicular Lymphoma
• Ibrance Receives an Expanded Indication in Breast Cancer
• Kyprolis Receives New Indication for Relapsed or Refractory Multiple Myeloma
• Venclexta First BCL-2 Targeted Drug Approved for Patients with CLL plus 17p Deletion

Read More ›

Patients who undergo gastrectomy are at high risk for poor bone health and vitamin D deficiency and should be assessed and treated for this, according to researchers from Australia who described these issues at the 2016 Gastrointestinal Cancers Symposium. Read More ›

Belgian researchers have developed an interactive cell phone–based tool that patients on oral chemotherapy can use daily to report adherence, adverse events, and other concerns. Read More ›

Although heart disease is the major cause of death in the United States, the public perception of cancer includes death, fear, stigma, lingering suffering and pain, loss of control, helplessness, and economic ruin. Read More ›

• ASCO Issues Guidelines for Developing Clinical Pathways That Promote Value-Based Care
• Second Cancer Risk Is High After Hodgkin Lymphoma
• Cancer Screening May Not Save Lives, a New Analysis Suggests

Read More ›

In the past few years, some of the classic phenotypes and associated cancer risk estimates of inherited cancer syndromes have been questioned. This is due partly to increased access to genetic testing as well as to the availability of next-generation sequencing (NGS) panels for inherited cancer. Read More ›

A steroid mouthwash can reduce the incidence of stomatitis associated with the use of everoli­mus. Data from the first prospective trial of prophylactic use of a steroid mouth rinse demonstrated a 26% incidence of stomatitis among patients with metastatic breast cancer who used the mouth rinse versus 67% in historical controls. Read More ›

At the 2016 Cancer Survivorship Symposium, Anthony L. Back, MD, Fred Hutchinson Cancer Research Center, University of Washington, highlighted 4 pivotal conversations that all cancer care providers must face, offering the requisite communication skills for helping patients cope with their disease. Read More ›

Preliminary results from a prospective study suggest that assessing psychological factors in cancer patients prior to initiating therapy can identify patients most at risk for emotional distress who might need psychosocial support. Read More ›

Increased levels of physical activity after a diagnosis of prostate cancer are associated with significantly better survival, according to the results of a new, large prospective cohort study. Read More ›